FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression

Fibroblast growth factor receptor 1 (FGFR1) is widely recognized as a key player in mammary carcinogenesis and associated with the prognosis and therapeutic response of breast cancers. With the aim of investigating the correlation between FGFR1 expression and estrogen receptor (ER) and exploring the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Qing, Guan, Shiming, Zhu, Mingjie, Huang, Hu, Wu, Junqiang, Dai, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013883/
https://www.ncbi.nlm.nih.gov/pubmed/33783288
http://dx.doi.org/10.1177/15330338211004935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013883/
https://www.ncbi.nlm.nih.gov/pubmed/33783288
http://dx.doi.org/10.1177/15330338211004935

Ejemplares similares